Comparative Efficacy and Speed of Onset of Action of Infliximab vs Golimumab in Ulcerative Colitis
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 18 (2) , 424-431.e7
Abstract
No abstract availableKeywords
Funding Information
- Gilead Sciences
- Tillotts Pharma
- Teva Pharmaceutical Industries
- Atlantic Healthcare
- AbbVie
- Takeda Pharmaceuticals U.S.A.
- Shire
- Merck
- Ferring Pharmaceuticals
- Bristol-Myers Squibb
- Crohn's and Colitis Foundation (404614, UL1TR001442)
- Pfizer
- Seres Therapeutics
- GlaxoSmithKline
- Novo Nordisk
- Johnson and Johnson
- American College of Gastroenterology
- National Institute of Diabetes and Digestive and Kidney Diseases
- Janssen Pharmaceutica
- National Institutes of Health (K23DK117058)
This publication has 27 references indexed in Scilit:
- Systematic review with meta‐analysis: the efficacy of a second anti‐TNF in patients with inflammatory bowel disease whose previous anti‐TNF treatment has failedAlimentary Pharmacology & Therapeutics, 2015
- Decreasing trends in hospitalizations during anti-TNF therapy are associated with time to anti-TNF therapy: Results from two referral centresDigestive and Liver Disease, 2014
- Biological Agents for Moderately to Severely Active Ulcerative ColitisAnnals of Internal Medicine, 2014
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative ColitisGastroenterology, 2014
- Longitudinal Data Analysis for Generalized Linear Models Under Participant-Driven Informative Follow-up: An Application in Maternal Health EpidemiologyAmerican Journal of Epidemiology, 2009
- Treatment of ulcerative colitis from the patient’s perspective: a survey of preferences and satisfaction with therapyAlimentary Pharmacology & Therapeutics, 2009
- Clinical Pharmacokinetics and Use??of??InfliximabClinical Pharmacokinetics, 2007
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Antibody Pharmacokinetics and PharmacodynamicsJournal of Pharmaceutical Sciences, 2004
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987